Professor Eileen Ingham
Professor of Medical Immunology
University of Leeds
Tissue Replacement and Regeneration
Graduated with a BSc in Biochemistry & Microbiology (1975) and obtained a PhD in Immunology (1979) from the University of Leeds. Appointed to reader in 1998 and present position in 2001.
She has published over 200 peer-reviewed papers. She was a co-founder of the Institute of Medical & Biological Engineering (iMBE: http://www.imbe.org.uk) at the University of Leeds and currently acts as Deputy Director. She is a founder member of the White Rose Biomaterials and Tissue Engineering Group (BITEG). She is Group leader of the Regenerative medicine group of the NIHR Biomedical Research Unit in Musculoskeletal Disease (£6 million). Research is also funded by BBSRC, MRC, NIH, arc, DTI and industry. She is an academic founder and director of Tissue Regenix, a University spin-out company founded in May 2006 which has recently won second round investment of £3.3 million to take their regenerative acellular biological scaffolds through to clinical trials.
Research interests are the biological effects of prosthetic wear debris (polyethylene, ceramic and metal particles) and regenerative medicine/ tissue engineering. Research in the latter has focussed upon the development of immunocompatible acellular scaffolds for orthopaedic and cardiovascular applications using xenogeneic and allogeneic natural tissues.
Academic collaborations in Japan, China, USA and South America as well as the UK.
Together with John Fisher (Mechanical Engineering), she is a recipient of an EPSRC Portfolio Partnership Award on Tissue Replacement and Regeneration (2003-2008; £2.2 million).